Log in

BLS BLS Pharmaceuticals Limited ASX · Australia

BLS Pharmaceuticals (BLS) news

BLS Pharmaceuticals Limited is a public biotech or pharmaceutical company listed on ASX under the ticker BLS, recorded under Australia. The directory classifies it as Pharmaceutical manufacturing and medicinal cannabinoids/psychedelics. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest BLS Pharmaceuticals news

We have not published a story on BLS Pharmaceuticals yet. When there is news, it will appear here.

Questions about BLS Pharmaceuticals

What is the ticker symbol of BLS Pharmaceuticals?

BLS Pharmaceuticals Limited trades under the ticker BLS on ASX.

Where is BLS Pharmaceuticals listed?

BLS Pharmaceuticals Limited is listed on ASX.

Which country or territory is BLS Pharmaceuticals listed under?

Our directory records BLS Pharmaceuticals Limited under Australia.

What does BLS Pharmaceuticals do?

Our directory classifies BLS Pharmaceuticals Limited as: Pharmaceutical manufacturing and medicinal cannabinoids/psychedelics. This is a directory classification, not a description of the pipeline.

What is the ISIN of BLS Pharmaceuticals?

The ISIN recorded for BLS Pharmaceuticals Limited is AU0000477796.

Does aibio.space cover BLS Pharmaceuticals?

aibio.space lists BLS Pharmaceuticals Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to BLS Pharmaceuticals?

Companies in our directory listed in the same country and business area as BLS Pharmaceuticals: Noxopharm, Microba Life Sciences, Entropy Neurodynamics, Prescient Therapeutics, Identifai Genetics, IDT Australia.

Investor discussion: BLS Pharmaceuticals

Members talk about BLS Pharmaceuticals (BLS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open ASX:BLS on TradingView.

Listing details

BLS Pharmaceuticals Limited is a public biotech or pharmaceutical company listed on ASX under the ticker BLS, recorded under Australia. The directory classifies it as Pharmaceutical manufacturing and medicinal cannabinoids/psychedelics. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
BLS Pharmaceuticals Limited
Ticker
BLS
Listing
ASX
Country or territory
Australia
Business scope
Pharmaceutical manufacturing and medicinal cannabinoids/psychedelics
ISIN
AU0000477796
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.